Trulieve Cannabis Corp. (TCNNF) — SEC Filings

Trulieve Cannabis Corp. (TCNNF) — 26 SEC filings. Latest: 8-K (Dec 17, 2025). Includes 10 8-K, 6 10-Q, 4 SC 13G/A.

View Trulieve Cannabis Corp. on SEC EDGAR

Overview

Trulieve Cannabis Corp. (TCNNF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 9, 2025: Trulieve Cannabis Corp. filed an 8-K on December 9, 2025, reporting an event that occurred on December 8, 2025. The filing is categorized under 'Other Events' and includes 'Financial Statements and Exhibits'. Specific details regarding the nature of the event or any financial figures are not provide

Sentiment Summary

Across 26 filings, the sentiment breakdown is: 2 bearish, 23 neutral, 1 mixed. The dominant filing sentiment for Trulieve Cannabis Corp. is neutral.

Filing Type Overview

Trulieve Cannabis Corp. (TCNNF) has filed 10 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 4 SC 13G/A, 1 DEFA14A, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (26)

Trulieve Cannabis Corp. SEC Filing History
DateFormDescriptionRisk
Dec 17, 20258-K8-K Filing
Dec 9, 20258-KTrulieve Cannabis Corp. Files 8-Klow
Nov 5, 202510-QTrulieve Narrows Q3 Loss to $28.8M Amid Revenue Growth, SG&A Cutsmedium
Nov 4, 20258-KTrulieve Cannabis Corp. Files 8-Klow
Aug 27, 20258-KTrulieve Cannabis Corp. Files 8-K on Officer/Director Changesmedium
Aug 6, 202510-QTrulieve's Q2 Loss Widens Amid Revenue Growth, Cash Declineshigh
Jun 13, 20258-KTrulieve Cannabis Corp. Files 8-K on Officer Changes and Shareholder Votesmedium
May 7, 202510-QTrulieve Cannabis Corp. Files Q1 2025 10-Qmedium
Apr 29, 2025DEF 14ATrulieve Cannabis Corp. Executive Compensation Details for FY2024medium
Mar 7, 20258-KTrulieve Cannabis Corp. Files 8-K with Officer/Director Changesmedium
Feb 27, 202510-KTrulieve Cannabis Corp. Files 2024 10-Kmedium
Nov 14, 2024SC 13G/ASC 13G/A Filing
Nov 5, 202410-QTrulieve Cannabis Corp. Files Q3 2024 10-Qmedium
Sep 18, 2024SC 13G/ASC 13G/A Filing
Aug 6, 202410-QTrulieve Cannabis Corp. Files Q2 2024 10-Qmedium
Jun 13, 20248-KTrulieve Cannabis Corp. Announces Board and Executive Changesmedium
May 9, 202410-QTrulieve Cannabis Corp. Files 10-Q for Period Ending March 31, 2024medium
Apr 30, 2024DEFA14ATrulieve Cannabis Corp. Files Proxy Materialslow
Apr 29, 2024DEF 14ATrulieve Cannabis Corp. Files Definitive Proxy Statement for 2024 Annual Meetinglow
Apr 23, 20248-KTrulieve Cannabis Corp. Announces Board and Executive Changesmedium

Risk Profile

Risk Assessment: Of TCNNF's 19 recent filings, 1 were flagged as high-risk, 13 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Trulieve Cannabis Corp. Financial Summary (10-Q, Nov 5, 2025)
MetricValue
Revenue$288.19M
Net Income$(28.78M)
EPS$(0.11)
Cash Position$449.20M
Total Assets$2,941.62M
Total Debt$1,755.34M

Key Executives

  • Florida

Industry Context

The cannabis industry continues to navigate a complex regulatory environment, with evolving state-level legalization and federal prohibition creating unique operational and financial challenges. Companies like Trulieve face intense competition, supply chain complexities, and significant tax burdens, particularly Section 280E of the Internal Revenue Code, which limits deductions for businesses selling Schedule I controlled substances.

Top Tags

cannabis (5) · 10-Q (4) · Cannabis Industry (3) · corporate-governance (3) · financials (3) · Trulieve Cannabis (3) · officer-changes (2) · executive-compensation (2) · 10-K (2) · management-change (2)

Key Numbers

Trulieve Cannabis Corp. Key Metrics
MetricValueContext
Q3 2025 Revenue$288.19MIncreased from $284.28M in Q3 2024, showing modest growth.
Q3 2025 Net Loss$(28.78M)Significantly narrowed from $(61.86M) in Q3 2024, indicating improved profitability.
Q3 2025 SG&A Expenses$99.02MDecreased from $148.62M in Q3 2024, reflecting effective cost control.
Cash and Cash Equivalents$449.20MIncreased from $238.80M at Dec 31, 2024, boosting liquidity.
Net Cash from Operations (9M 2025)$213.61MStrong operating cash flow for the nine months ended September 30, 2025.
Uncertain Tax Position Liabilities$616.32MIncreased from $445.22M at Dec 31, 2024, a significant financial risk.
Q3 2025 Basic and Diluted EPS$(0.11)Improved from $(0.32) in Q3 2024, reflecting the narrowed net loss.
Shares Outstanding191,144,583As of September 30, 2025, indicating stable share count.
Net Loss$15.0MQ2 2025 net loss, a significant decline from $5.0M net income in Q2 2024.
Total Revenues$290.0MQ2 2025 revenues, a 3.6% increase from $280.0M in Q2 2024.
Revenue Growth3.6%Percentage increase in Q2 2025 revenues compared to Q2 2024.
Six-Month Net Loss$25.0MFor the six months ended June 30, 2025, compared to $10.0M net loss in 2024.
Reporting PeriodQ1 2025First quarter of 2025 financial performance
As of Date2025-03-31End of the reporting period for the 10-Q
Fiscal Year2024Reporting period for the 10-K

Related Companies

CURLF · GTBIF · MSOS

Frequently Asked Questions

What are the latest SEC filings for Trulieve Cannabis Corp. (TCNNF)?

Trulieve Cannabis Corp. has 26 recent SEC filings from Jan 2024 to Dec 2025, including 10 8-K, 6 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of TCNNF filings?

Across 26 filings, the sentiment breakdown is: 2 bearish, 23 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Trulieve Cannabis Corp. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Trulieve Cannabis Corp. (TCNNF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Trulieve Cannabis Corp.?

Key financial highlights from Trulieve Cannabis Corp.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for TCNNF?

The investment thesis for TCNNF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Trulieve Cannabis Corp.?

Key executives identified across Trulieve Cannabis Corp.'s filings include Florida.

What are the main risk factors for Trulieve Cannabis Corp. stock?

Of TCNNF's 19 assessed filings, 1 were flagged high-risk, 13 medium-risk, and 5 low-risk.

What are recent predictions and forward guidance from Trulieve Cannabis Corp.?

Forward guidance and predictions for Trulieve Cannabis Corp. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.